These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7940435)

  • 1. Atrial natriuretic peptide levels in the sleep apnoea/hypopnoea syndrome.
    Mackay TW; Fitzpatrick MF; Freestone S; Lee MR; Douglas NJ
    Thorax; 1994 Sep; 49(9):920-1. PubMed ID: 7940435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
    Kita H; Ohi M; Chin K; Noguchi T; Otsuka N; Tsuboi T; Itoh H; Nakao K; Kuno K
    J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.
    Krieger J; Laks L; Wilcox I; Grunstein RR; Costas LJ; McDougall JG; Sullivan CE
    Clin Sci (Lond); 1989 Oct; 77(4):407-11. PubMed ID: 2530023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome.
    Schäfer H; Ehlenz K; Ewig S; Hasper E; Koehler U; Latzelsberger J; Tasci S; Lüderitz B
    J Sleep Res; 1999 Sep; 8(3):205-10. PubMed ID: 10476007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the changes of urinary uric acid, ANP, renin and aldosterone in sleep apnea syndrome patients].
    Xiao Y; Yin K; Zheng P
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):27-30. PubMed ID: 11778177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome.
    Baruzzi A; Riva R; Cirignotta F; Zucconi M; Cappelli M; Lugaresi E
    Sleep; 1991 Feb; 14(1):83-6. PubMed ID: 1839810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.
    Krieger J; Follenius M; Sforza E; Brandenberger G; Peter JD
    Clin Sci (Lond); 1991 May; 80(5):443-9. PubMed ID: 1851683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-heart rate responses to alpha-adrenergic stimulation and hormonal regulation in normotensive patients with obstructive sleep apnea.
    Maillard D; Fineyre F; Dreyfuss D; Djedaini K; Blanchet F; Paycha F; Dussaule JC; Nitenberg A
    Am J Hypertens; 1997 Jan; 10(1):24-31. PubMed ID: 9008245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome.
    Ichioka M; Hirata Y; Inase N; Tojo N; Yoshizawa M; Chida M; Miyazato I; Taniai S; Marumo F
    Respiration; 1992; 59(3):164-8. PubMed ID: 1439228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide in habitual snorers.
    Partinen M; Telakivi T; Kaukiainen A; Salmi T; Färkkilä M; Saijonmaa O; Fyhrquist F
    Ann Med; 1991 Apr; 23(2):147-51. PubMed ID: 1829903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide, renin activity, aldosterone, urine volume and electrolytes during a 24-h sleep-wake cycle in man.
    Leppäluoto J; Ruskoaho H
    Acta Physiol Scand; 1990 May; 139(1):47-53. PubMed ID: 2141447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal changes in atrial natriuretic peptide levels and plasma renin activity during treatment of pulmonary embolism.
    Tan AC; van Loenhout TT; Tan HS; Kloppenborg PW; Benraad TJ
    Am J Hypertens; 1989 Jul; 2(7):570-2. PubMed ID: 2527045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal control of sodium and water excretion in obstructive sleep apnoea.
    Krieger J
    Scand J Urol Nephrol Suppl; 1995; 173():65-8; discussion 68-9. PubMed ID: 8719571
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome.
    Davidson BJ; Rea CD; Valenzuela GJ
    Fertil Steril; 1988 Nov; 50(5):743-6. PubMed ID: 2972566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hypoxia and atrial natriuretic peptide on aldosterone secretion in healthy subjects.
    Westendorp RG; Roos AN; Simons M; Wertheim W; Bosch FH; Frölich M; Meinders AE
    J Appl Physiol (1985); 1993 Aug; 75(2):534-9. PubMed ID: 8226450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma brain natriuretic peptide in obstructive sleep apnea.
    Svatikova A; Shamsuzzaman AS; Wolk R; Phillips BG; Olson LJ; Somers VK
    Am J Cardiol; 2004 Aug; 94(4):529-32. PubMed ID: 15325948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome.
    Hwang SJ; Tsai JH; Lai YH; Chen JH
    Nephron; 1991; 58(3):330-8. PubMed ID: 1832746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
    Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G
    Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
    Shigematsu S; Iwasaki T; Aizawa T; Ishihara M; Shinoda T; Yamada T; Sato A; Takemura Y
    Horm Metab Res; 1989 Sep; 21(9):514-8. PubMed ID: 2531114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.